首页> 外文期刊>Chemico-biological interactions >Molecular epidemiological studies in 1,3-butadiene exposed Czech workers: female-male comparisons.
【24h】

Molecular epidemiological studies in 1,3-butadiene exposed Czech workers: female-male comparisons.

机译:1,3-丁二烯暴露的捷克工人的分子流行病学研究:男女比较。

获取原文
获取原文并翻译 | 示例
           

摘要

Results of a recent molecular epidemiological study of 1,3-butadiene (BD) exposed Czech workers, conducted to compare female to male responses, have confirmed and extended the findings of a previously reported males only study (HEI Research Report 116, 2003). The initial study found that urine concentrations of the metabolites 1,2-dihydroxy-4-(acetyl) butane (M1) and 1-dihydroxy-2-(N-acetylcysteinyl)-3-butene (M2) and blood concentrations of the hemoglobin adducts N-[2-hydroxy-3-butenyl] valine (HB-Val) and N-[2,3,4-trihydroxy-butyl] valine (THB-Val) constitute excellent biomarkers of exposure, both being highly correlated with BD exposure levels, and that GST genotypes modulate at least one metabolic pathway, but that irreversible genotoxic effects such as chromosome aberrations and HPRT gene mutations are neither associated with BD exposure levels nor with worker genotypes (GST [glutathione-S-transferase]-M1, GSTT1, CYP2E1 (5' promoter), CYP2E1 (intron 6), EH [epoxide hydrolase] 113, EH139, ADH [alcohol dehydrogenase]2 and ADH3). The no observed adverse effect level (NOAEL) for chromosome aberrations and HPRT mutations was 1.794 mg/m(3) (0.812 ppm)--the mean exposure level for the highest exposed worker group in this initial study. The second Czech study, reported here, initiated in 2003, included 26 female control workers, 23 female BD exposed workers, 25 male control workers and 30 male BD exposed workers (some repeats from the first study). Multiple external exposure measurements (10 full 8-h shift measures by personal monitoring per worker) over a 4-month period before biological sample collections showed that BD workplace levels were lower than in the first study. Mean 8-h TWA exposure levels were 0.008 mg/m(3) (0.0035 ppm) and 0.397 mg/m(3) (0.180 ppm) for female controls and exposed, respectively, but with individual single 8-h TWA values up to 9.793 mg/m(3) (4.45 ppm) in the exposed group. Mean male 8-h TWA exposure levels were 0.007 mg/m(3) (0.0032 ppm) and 0.808 mg/m(3) (0.370 ppm) for controls and exposed, respectively; however, the individual single 8-h TWA values up to 12.583 mg/m(3) (5.72 ppm) in the exposed group. While the urine metabolite concentrations for both M1 and M2 were elevated in exposed compared to control females, the differences were not significant, possibly due to the relatively low BD exposure levels. For males, with greater BD exposures, the concentrations of both metabolites were significantly elevated in urine from exposed compared to control workers. As in the first study, urine metabolite excretion patterns in both sexes revealed conjugation to be the minor detoxification pathway (yielding the M2 metabolite) but both M1 and M2 concentration values were lower in males in this second study compared to their concentrations in the first, reflecting the lower external exposures of males in this second study compared to the first. Of note, females showed lower concentrations of both M1 and M2 metabolites in the urine per unit of BD exposure than did males while exhibiting the same M1/(M1+M2) ratio, reflecting the same relative utilization of the hydrolytic (producing M1) and the conjugation (producing M2) detoxification pathways as males. Assays for the N,N-(2,3-dihydroxy-1,4-butadyl) valine (pyr-Val) hemoglobin (Hb) adduct, which is specific for the highly genotoxic 1,2,3,4-diepoxybutane (DEB) metabolite of BD, have been conducted on blood samples from all participants in this second Czech study. Any adduct that may have been present was below the limits of quantitation (LOQ) for this assay for all samples, indicating that production of this important BD metabolite in humans is below levels produced in both mice and rats exposed to as little as 1.0 ppm BD by inhalation (J.A. Swenberg, M.G. Bird, R.J. Lewis, Future directions in butadiene risk assessment, Chem. Biol. Int. (2006), this issue). Results of assays for the HB-Val and THB-Val hemoglobin adducts are pending. HPRT mutations, determined
机译:最近对暴露于1,3-丁二烯(BD)的捷克工人进行的分子流行病学研究的结果(用于比较女性与男性的反应)证实并扩展了先前报道的仅男性研究的结果(HEI研究报告116,2003)。初步研究发现,代谢物1,2-二羟基-4-(乙酰基)丁烷(M1)和1-二羟基-2-(N-乙酰基半胱氨酰)-3-丁烯(M2)的尿液浓度和血红蛋白的血药浓度N- [2-羟基-3-丁烯基]缬氨酸(HB-Val)和N- [2,3,4-三羟基丁基]缬氨酸(THB-Val)的加合物构成了良好的暴露生物标志物,两者均与BD高度相关暴露水平,以及GST基因型调节至少一种代谢途径,但是不可逆的遗传毒性作用(例如染色体畸变和HPRT基因突变)与BD暴露水平或工人基因型均无关(GST [谷胱甘肽-S-转移酶] -M1, GSTT1,CYP2E1(5'启动子),CYP2E1(内含子6),EH [环氧化物水解酶] 113,EH139,ADH [醇脱氢酶] 2和ADH3)。没有观察到的染色体畸变和HPRT突变的不良反应水平(NOAEL)为1.794 mg / m(3)(0.812 ppm),这是该初始研究中最高暴露人群的平均暴露水平。在此报告的第二项捷克研究始于2003年,包括26名女性对照工人,23名女性BD暴露工人,25名男性对照工人和30名男性BD暴露工人(与第一次研究重复)。在收集生物样本之前的4个月内,进行了多次外部暴露测量(每位工人10个人通过全时监控8小时全班轮班测量),结果表明BD工作场所的水平低于第一项研究。女性对照和暴露者的平均8小时TWA暴露水平分别为0.008 mg / m(3)(0.0035 ppm)和0.397 mg / m(3)(0.180 ppm),但单个8h TWA值最高暴露组9.793 mg / m(3)(4.45 ppm)。对照和暴露的男性平均8小时TWA暴露水平分别为0.007 mg / m(3)(0.0032 ppm)和0.808 mg / m(3)(0.370 ppm);但是,暴露组的单个8小时TWA值高达12.583 mg / m(3)(5.72 ppm)。虽然与对照女性相比,暴露的M1和M2尿液代谢物浓度均升高,但差异并不显着,可能是由于相对较低的BD暴露水平。对于男性,与对照工人相比,BD暴露量更大,尿液中两种代谢物的浓度均显着升高。与第一项研究一样,男女两性尿液代谢产物的排泄方式表明,共轭是次要的排毒途径(产生M2代谢产物),但与第一项研究中的浓度相比,第二项研究中男性的M1和M2浓度值均较低,反映了与第二项研究相比,第二项研究中男性的外部暴露较低。值得注意的是,女性每单位BD暴露尿液中M1和M2代谢物的浓度均低于男性,而M1 /(M1 + M2)比率相同,反映了水解物(产生M1)和男性的共轭(产生M2)排毒途径。 N,N-(2,3-二羟基-1,4-丁二酰基)缬氨酸(pyr-Val)血红蛋白(Hb)加合物的分析方法,该加合物对具有高遗传毒性的1,2,3,4-二环氧丁烷(DEB)具有特异性)BD的代谢产物已在第二项捷克研究的所有参与者的血液样本中进行。对于所有样品,任何可能存在的加合物均低于该分析的定量限(LOQ),这表明人体内这种重要的BD代谢产物的产生低于暴露于低至1.0 ppm BD的小鼠和大鼠的产生的水平通过吸入(JA Swenberg,MG Bird,RJ Lewis,《丁二烯风险评估的未来方向》,《化学生物学杂志》(2006年),本期)。 HB-Val和THB-Val血红蛋白加合物的测定结果尚待确定。 HPRT突变,已确定

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号